Beyond Raf-1 inhibition: RKIP's multifaceted roles in cellular homeostasis.

Raf Kinase Inhibitory Protein (RKIP), also known as PEBP1, is a multifunctional modulator of intracellular signaling with pivotal roles in cellular homeostasis, cancer suppression, cardiac physiology, and neurobiology. Initially characterized by its inhibition of the Raf-1/MEK/ERK cascade, RKIP has since emerged as a dynamic regulator of numerous pathways, including NF-κB, GRK2, GSK3β, and Aurora B kinase. RKIP activity is modulated through phosphorylation-dependent conformational shifts that dictate its binding partners and regulatory outcomes. In oncology, RKIP acts as a metastasis suppressor by promoting let-7 microRNA expression and inhibiting pro-metastatic genes such as HMGA2, BACH1, MMPs, and CXCR4. In the nervous system, RKIP influences synaptic signaling, pain perception, and neuroprotection, while in cardiomyocytes, it enhances β-adrenergic signaling and protects mitochondria under stress. Dysregulation of RKIP is implicated in cancer progression, heart failure, and neurodegenerative diseases. Ongoing research into pharmacological modulation of RKIP holds promise for novel therapeutic interventions across diverse pathologies.